RedHill Biopharma (RDHL) Retained Earnings (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Retained Earnings of -$413.8 million for Q4 2025, little changed year-over-year from -$412.7 million in Q4 2024, and up 1.04% quarter-over-quarter from -$418.1 million in Q2 2025.
RedHill Biopharma (RDHL) Retained Earnings (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Retained Earnings for 15 consecutive years, with -$413.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings changed 0.25% year-over-year to -$413.8 million; the TTM figure through Dec 2025 stood at -$413.8 million (changed 0.25% YoY), while the FY2025 annual figure was -$413.8 million, changed 0.25% from the prior year.
- Retained Earnings rose to -$413.8 million in Q4 2025 per RDHL's latest filing, from -$418.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$302.3 million in Q1 2021 and bottomed at -$433.9 million in Q4 2022.
- Historically, Retained Earnings has averaged -$387.8 million across 5 years, with a median of -$397.2 million in 2022.
- Annual changes were most pronounced in 2021 — Retained Earnings sank 35.82% — and 2023, when it advanced 6.02%.
- RedHill Biopharma's Retained Earnings stood at -$367.9 million in 2021, then decreased by 17.94% to -$433.9 million in 2022, then increased by 6.02% to -$407.7 million in 2023, then dropped by 1.73% to -$414.8 million in 2024, then advanced by 0.25% to -$413.8 million in 2025.
- Business Quant data shows RDHL's Retained Earnings at -$413.8 million in Q4 2025, -$418.1 million in Q2 2025, and -$414.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | -413.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -413.76 Mn |
| Jun 30, 2025 | -418.12 Mn |
| Dec 31, 2024 | -414.80 Mn |
| Jun 30, 2024 | -410.06 Mn |
| Dec 31, 2023 | -407.74 Mn |
| Jun 30, 2023 | -382.01 Mn |
| Mar 31, 2023 | -383.48 Mn |
| Dec 31, 2022 | -433.86 Mn |
| Sep 30, 2022 | -431.27 Mn |
| Jun 30, 2022 | -397.18 Mn |
| Mar 31, 2022 | -382.70 Mn |
| Dec 31, 2021 | -367.87 Mn |
| Sep 30, 2021 | -345.37 Mn |
| Jun 30, 2021 | -326.17 Mn |
| Mar 31, 2021 | -302.33 Mn |
| Dec 31, 2020 | -280.33 Mn |
| Sep 30, 2020 | -257.09 Mn |
| Jun 30, 2020 | -240.14 Mn |
| Mar 31, 2020 | -224.72 Mn |
| Dec 31, 2019 | -208.36 Mn |